Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alberts D. S., Chen H. S., Salmon S. E. In vitro drug assay: pharmacologic considerations. Prog Clin Biol Res. 1980;48:197–207. [PubMed] [Google Scholar]
- Elliott J. A., Ahmedzai S., Hole D., Dorward A. J., Stevenson R. D., Kaye S. B., Banham S. W., Stack B. H., Calman K. C. Vindesine and cisplatin combination chemotherapy compared with vindesine as a single agent in the management of non-small cell lung cancer: a randomized study. Eur J Cancer Clin Oncol. 1984 Aug;20(8):1025–1032. doi: 10.1016/0277-5379(84)90104-4. [DOI] [PubMed] [Google Scholar]
- Merry S., Fetherston C. A., Kaye S. B., Freshney R. I., Plumb J. A. Resistance of human glioma to adriamycin in vitro: the role of membrane transport and its circumvention with verapamil. Br J Cancer. 1986 Jan;53(1):129–135. doi: 10.1038/bjc.1986.18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rogan A. M., Hamilton T. C., Young R. C., Klecker R. W., Jr, Ozols R. F. Reversal of adriamycin resistance by verapamil in human ovarian cancer. Science. 1984 Jun 1;224(4652):994–996. doi: 10.1126/science.6372095. [DOI] [PubMed] [Google Scholar]
- Simmonds A. P., Hamilton P. S., Kerr H., Harvey K., Moyes P., Davidson K. G., Faichney A. Drug sensitivity of non small cell carcinoma of lung by clonogenic assay in several media. Br J Cancer. 1986 Oct;54(4):587–594. doi: 10.1038/bjc.1986.213. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tsuruo T., Iida H., Naganuma K., Tsukagoshi S., Sakurai Y. Promotion by verapamil of vincristine responsiveness in tumor cell lines inherently resistant to the drug. Cancer Res. 1983 Feb;43(2):808–813. [PubMed] [Google Scholar]
- Tsuruo T., Iida H., Tsukagoshi S., Sakurai Y. Potentiation of vincristine and Adriamycin effects in human hemopoietic tumor cell lines by calcium antagonists and calmodulin inhibitors. Cancer Res. 1983 May;43(5):2267–2272. [PubMed] [Google Scholar]